Notice 7 April 2020 Publication Notice: Hydroxychloroquine and azithromycin as a treatment of COVID-19 - Does not meet standards A highly cited paper entitled, 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [https://www.ncbi.nlm.
Scientific Papers 6 April 2020 SARS-CoV-2 replicates in the throat, shedding beyond symptomatic period Pharyngeal virus shedding was very high during the first week of symptoms. Infectious virus was readily isolated from throat- and lung-derived samples, but not from
Therapeutics 6 April 2020 Therapeutic plasma exchange for fulminant COVID-19 - Advocacy article Chinese authorities have reported success treating infected patients with donated plasma from survivors of the illness, the proposed benefit being protective antibodies formed by the
Clinical Trials 6 April 2020 rsACE2 may Inhibit COVID-19. Clinical Trial to commence An international team that previously offered the first genetic evidence that Angiotensin converting enzyme 2 (ACE2) is the critical receptor for SARS-CoV and that ACE2
Clinical Trials 6 April 2020 Clinical Trial: Hyperbaric Oxygen for COVID-19 Patients Brief Summary: Hyperbaric oxygen therapy (HBOT) treatment will be provided to patients as an adjunct to standard therapy for a cohort of 40 COVID19-positive patients
Therapeutics 6 April 2020 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Abstract Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, the application of heparin in COVID‐19 has been recommended
News and Reports 6 April 2020 Covid-19: four fifths of cases are asymptomatic, China figures indicate New evidence has emerged from China indicating that the large majority of coronavirus infections do not result in symptoms. Chinese authorities began publishing daily figures
News and Reports 6 April 2020 Results of 15-Day Study on COVID-19 and Social Distancing Measures A recent study from researchers at iiSM.ORG confirms that the spread of coronavirus in the US has been substantially slowed by Social Distancing (S.
Scientific Papers 6 April 2020 Stability of SARS-CoV-2 in different environmental conditions The stability of SARS-CoV-2 in different environmental conditions. Notably, casual contact with a surface such as printed or tissue papers does not have the potential
Scientific Papers 6 April 2020 Airborne Transmission of COVID-19 - evidence Much remains unknown about COVID-19 transmission. Researchers have evaluated potential transmission routes from two community COVID-19 outbreaks and have concluded that Airborne spread of COVID-19
Scientific Papers 4 April 2020 Ivermectin is a potent inhibitor of SARS-CoV-2 Ivermectin is an inhibitor of SARS-CoV-2
Visualisations 3 April 2020 Google releases 'Community Mobility Reports' Google is publishing an early release of its COVID-19 Community Mobility Reports to provide insights into what has changed in response to work from home, shelter in place, and other policies aimed at flattening the curve of this pandemic.
Scientific Papers 30 March 2020 SARS-CoV-2 integrity on contaminated surfaces stays intact for hours and even days: Study. A letter to the editor titled, 'Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 [https://www.nejm.org/doi/10.1056/NEJMc2004973]
29 March 2020 Social Distancing, Masks, etc. Lessons from China by its Director of Disease Control George Fu Gao [https://en.wikipedia.org/wiki/George_F._Gao], director-general of the Chinese Center for Disease Control and Prevention, in an interview with
Visualisations 29 March 2020 Meta Visualisation of COVID-19 Pandemic Alexey Pakhomov has built a meta aggregator of data from multiple sources such as the Johns Hopkins CSV [https://github.com/CSSEGISandData/COVID-19/tree/master/
